Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Feb;159(2):64-79.
doi: 10.1016/j.trsl.2011.08.001. Epub 2011 Aug 31.

Molecular genetic studies of complex phenotypes

Ali J Marian  1
Affiliations
Review

Molecular genetic studies of complex phenotypes

Ali J Marian. Transl Res. 2012 Feb.

Abstract

The approach to molecular genetic studies of complex phenotypes evolved considerably during the recent years. The candidate gene approach, which is restricted to an analysis of a few single-nucleotide polymorphisms (SNPs) in a modest number of cases and controls, has been supplanted by the unbiased approach of genome-wide association studies (GWAS), wherein a large number of tagger SNPs are typed in many individuals. GWAS, which are designed on the common disease-common variant hypothesis (CD-CV), identified several SNPs and loci for complex phenotypes. However, the alleles identified through GWAS are typically not causative but rather in linkage disequilibrium (LD) with the true causal variants. The common alleles, which may not capture the uncommon and rare variants, account only for a fraction of heritability of the complex traits. Hence, the focus is being shifted to rare variants-common disease (RV-CD) hypothesis, surmising that rare variants exert large effect sizes on the phenotype. In conjunctional with this conceptual shift, technologic advances in DNA sequencing techniques have dramatically enhanced whole genome or whole exome sequencing capacity. The sequencing approach affords identification of not only the rare but also the common variants. The approach-whether used in complementation with GWAS or as a stand-alone approach-could define the genetic architecture of the complex phenotypes. Robust phenotyping and large-scale sequencing studies are essential to extract the information content of the vast number of DNA sequence variants (DSVs) in the genome. To garner meaningful clinical information and link the genotype to a phenotype, the identification and characterization of a large number of causal fields beyond the information content of DNA sequence variants would be necessary. This review provides an update on the current progress and limitations in identifying DSVs that are associated with phenotypic effects.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: There is no conflict of interest to declare. The author have read the journal’s policy on disclosure of potential conflicts of interes

Figures

Figure 1
Figure 1. Gradients of disease prevalence and the effect sizes of the causative alleles
Prevalence of disease, number of determinant DNA sequence variants (DSVs) and their effect sizes are shown. Single gene disorders are caused by rare variants with large effect sizes. In addition to the main causal variant, which typically exhibits a Mendelian pattern of inheritance, several other non-Mendelian variants contribute to expression of the phenotype. On the opposite end of the spectrum are the common complex traits, which are caused, in part, by the cumulative effects of a very large number of DSVs, each imparting a modest effect size. In oligogenetic phenotypes, several alleles with moderate size effects and a large number of alleles with small effect sizes contribute to the phenotype.
Figure 2
Figure 2. Determinants of a complex phenotype
Cardiac hypertrophy is used as an example of a complex phenotype and various other potential determinants of phenotypic expression of cardiac hypertrophy, including genetics, genomics and external environmental factors are shown (not meant to indicate scale of effect sizes).
Figure 3
Figure 3. Non-homogenous target capture
A segment of LMNA gene showing locations of exons (blue boxes), capture regions (green boxes; exons plus 150bp flanking sequences), capture probes (purple-blue boxes) and depth of coverage of sequence reads from one (light gray) and 2 rounds of capture (dark grey). The depth of coverage is reflected by the shades of grey.
Figure 4
Figure 4. An example of sequence output of a Next Generation Sequencing (NGS) platform
Multiple copies of each DNA fragment is sequenced in parallel and analyzed. Four heterozygous nucleotides are identified in the sequenced fragment. The Figure illustrates the significance of an adequate coverage of each nucleotide for robust allele calling as well the potential for mis-calling because of inadequate coverage at each nucleotide position.
Figure 5
Figure 5. Approach to sub-genomic capture and sequencing
The diagram illustrates steps involved in target capture and sequencing. The steps include fragmentation of genomic DNA through sonication, adapter ligation, design of capture probes, and quality control to ensure specificity of hybridization, efficiency and uniformity of the capture. The analysis includes BLAST screening against repetitive DNAs and for specificity. Commonly several base long priming sites are added to the ends of all probes, allowing amplification of the probe set following synthesis. Probe pools are amplified using primers to the flanking, common priming sites. Several hundred-fold molar excesses of each probe sequence are used in hybridization. Typically, after one round of capture and enrichment, targets are enriched several thousand-fold. The enriched targets are then loaded onto a NGS platform for parallel sequencing of DNA strands.
See this image and copyright information in PMC

Comment in

Similar articles

  • Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use.
    Brazel DM, Jiang Y, Hughey JM, Turcot V, Zhan X, Gong J, Batini C, Weissenkampen JD, Liu M; CHD Exome+ Consortium; Consortium for Genetics of Smoking Behaviour; Barnes DR, Bertelsen S, Chou YL, Erzurumluoglu AM, Faul JD, Haessler J, Hammerschlag AR, Hsu C, Kapoor M, Lai D, Le N, de Leeuw CA, Loukola A, Mangino M, Melbourne CA, Pistis G, Qaiser B, Rohde R, Shao Y, Stringham H, Wetherill L, Zhao W, Agrawal A, Bierut L, Chen C, Eaton CB, Goate A, Haiman C, Heath A, Iacono WG, Martin NG, Polderman TJ, Reiner A, Rice J, Schlessinger D, Scholte HS, Smith JA, Tardif JC, Tindle HA, van der Leij AR, Boehnke M, Chang-Claude J, Cucca F, David SP, Foroud T, Howson JMM, Kardia SLR, Kooperberg C, Laakso M, Lettre G, Madden P, McGue M, North K, Posthuma D, Spector T, Stram D, Tobin MD, Weir DR, Kaprio J, Abecasis GR, Liu DJ, Vrieze S. Brazel DM, et al. Biol Psychiatry. 2019 Jun 1;85(11):946-955. doi: 10.1016/j.biopsych.2018.11.024. Epub 2018 Dec 6. Biol Psychiatry. 2019. PMID: 30679032 Free PMC article.
  • Diversity in non-repetitive human sequences not found in the reference genome.
    Kehr B, Helgadottir A, Melsted P, Jonsson H, Helgason H, Jonasdottir A, Jonasdottir A, Sigurdsson A, Gylfason A, Halldorsson GH, Kristmundsdottir S, Thorgeirsson G, Olafsson I, Holm H, Thorsteinsdottir U, Sulem P, Helgason A, Gudbjartsson DF, Halldorsson BV, Stefansson K. Kehr B, et al. Nat Genet. 2017 Apr;49(4):588-593. doi: 10.1038/ng.3801. Epub 2017 Feb 27. Nat Genet. 2017. PMID: 28250455
  • Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I, Zhang Y, Ma SF, Flores C, Barber M, Huang Y, Broderick SM, Wade MS, Hysi P, Scuirba J, Richards TJ, Juan-Guardela BM, Vij R, Han MK, Martinez FJ, Kossen K, Seiwert SD, Christie JD, Nicolae D, Kaminski N, Garcia JGN. Noth I, et al. Lancet Respir Med. 2013 Jun;1(4):309-317. doi: 10.1016/S2213-2600(13)70045-6. Epub 2013 Apr 17. Lancet Respir Med. 2013. PMID: 24429156 Free PMC article.
  • Challenges in medical applications of whole exome/genome sequencing discoveries.
    Marian AJ. Marian AJ. Trends Cardiovasc Med. 2012 Nov;22(8):219-23. doi: 10.1016/j.tcm.2012.08.001. Epub 2012 Aug 24. Trends Cardiovasc Med. 2012. PMID: 22921985 Free PMC article. Review.
  • Medical DNA sequencing.
    Marian AJ. Marian AJ. Curr Opin Cardiol. 2011 May;26(3):175-80. doi: 10.1097/HCO.0b013e3283459857. Curr Opin Cardiol. 2011. PMID: 21415728 Free PMC article. Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science. 2001;291(5507):1304–51. - PubMed
    1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860–921. - PubMed
    1. Lander ES. Initial impact of the sequencing of the human genome. Nature. 2011 Feb 10;470(7333):187–97. - PubMed
    1. Blaxter M. Revealing the dark matter of the genome. Science. 2010 Dec 24;330(6012):1758–9. - PubMed
    1. Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP, et al. The Diploid Genome Sequence of an Individual Human. PLoSBiol. 2007;5(10):e254. - PMC - PubMed

Publication types

-